RedHill Biopharma (RDHL) Change in Cash (2012 - 2022)

RedHill Biopharma (RDHL) has 11 years of Change in Cash data on file, last reported at $4.8 million in Q4 2022.

• On a quarterly basis, Change in Cash fell 23.04% year-over-year to $4.8 million in Q4 2022; TTM through Dec 2022 was -$9.4 million, a 3516.67% decrease from a year earlier, with the FY2025 full-year figure at -$644000.0, up 32.99% from the prior year.
• Change in Cash for Q4 2022 stood at $4.8 million, up from -$11.8 million in the prior quarter.
• Over the last five years, Change in Cash for RDHL reached as high as $52.5 million in Q1 2020 and fell as low as -$59.4 million in Q2 2020.
• Historically, Change in Cash has averaged $178300.0 across 5 years, with a median of $1.0 million in 2019.
• Across the five-year window, Change in Cash surged 973.31% in 2020 and slumped 821.02% in 2021, its largest moves.
• Year by year, Change in Cash stood at $10.3 million in 2018, then surged by 67.7% to $17.3 million in 2019, then plunged by 82.19% to $3.1 million in 2020, then jumped by 101.13% to $6.2 million in 2021, then decreased by 23.04% to $4.8 million in 2022.
• Per Business Quant data, the three most recent Change in Cash figures were $4.8 million in Q4 2022, -$11.8 million in Q3 2022, and -$1.8 million in Q2 2022.